ロード中...
Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer
Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...
保存先:
主要な著者: | , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Elsevier
2022-06-01
|
シリーズ: | American Journal of Ophthalmology Case Reports |
主題: | |
オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2451993622002055 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|